Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, spoke with Politico about COVID-19 treatments, including monoclonal antibodies, antiviral drugs like Paxlovid and Remdesivir, and convalescent plasma, and the pursuit of new options.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH